No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec™/Glivec®)

Paul La Rosée, Lei Shen, Eric P. Stoffregen, Michael Deininger, Brian J. Druker

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec™/Glivec®)'. Together they form a unique fingerprint.

Medicine & Life Sciences